Signaling through FSH receptors on human umbilical vein endothelial cells promotes angiogenesis

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 5, 2014, Pages

  Stilley, Julie A ^a   Guan, Rongbin ^a   Duffy, Diane M ^b   Segaloff, Deborah L ^a  

^a UNIVERSITY OF IOWA   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; FOLLITROPIN RECEPTOR; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT FOLLITROPIN; VASCULOTROPIN 165;

ADULT; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MACACA FASCICULARIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND HEALING;

CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; FOLLICLE STIMULATING HORMONE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, FSH; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84899927065     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3186     Document Type: Article

References (38)

1. Khankin EV, Royle C, Karumanchi SA. Placental vasculature in health and disease. Semin Thromb Hemost. 2010;36:309-320.
2. Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5:173-192.
3. Rad u A, Pichon C, Camparo P, et al. Expression of follicle-stimulating hormone receptor in tumor blood vessels. N Engl J Med. 2010;363:1621-1630.
4. Zhu LL, Blair H, Cao J, et al. Blocking antibody to the-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis. Proc Natl Acad Sci USA. 2012;109:14574-14579.
5. Zhang M Tao YX Ryan GL Feng X Fanelli F Segaloff DL. Intrinsic differences in the response of the human lutropin receptor versus the human follitropin receptor to activating mutations J Biol Chem. 2007 282 25527-25539.
6. Vannier B, Loosfelt H, Meduri G, Pichon C, Milgrom E. Anti-human FSH receptor monoclonal antibodies: immunochemical and immunocytochemical characterization of the receptor. Biochemistry. 1996;35: 1358-1366.
7. Duffy DM, Dozier BL, Seachord CL. Prostaglandin dehydrogenase and prostaglandin levels in periovulatory follicles: implications for control of primate ovulation by prostaglandin E2. J Clin Endocrinol Metab. 2005;90:1021-1027.
8. Robinson LJ, Tourkova I, Wang Y, et al. FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteocla sts. Biochem Biophys Res Commun. 2010;394:12-17.
9. Zhu LL, Tourkova I, Yuen T, et al. Blocking FSH action attenuates osteoclastogenesis. Biochem Biophys ResCommun. 2012;422:54-58.
10. Ramaesh T, Logie JJ, Roseweir AK, et al. Kisspeptin-10 inhibits angiogenesis in human placental vessels ex vivo and endothelial cells in vitro. Endocrinology. 2010;151:5927-5934.
11. Wang K, Zheng J. Signaling regulation of fetoplacental angiogenesis. J Endocrinol. 2012;212:243-355.
12. Hunzicker-Dunn M, Maizels ET. FSH signaling pathways in immatur e granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell Signal. 2006;18:1351-1359.
13. Christenson LK, Stouffer RL. Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre-and periovulatory follicles. J Clin Endocrinol Metab. 1997;82:2135-2142.
14. Alam H, Weck J, Maizels E, et al. Role of the phosphatidylinositol-3- kinase and extracellular regulated kinase pathways in the induction of hypoxia-inducible factor (HIF)-1 activity and the HIF-1 target vascular endothe lial growth factor in ovarian granulosa cells in response to follicle-stimulating hormone. Endocrinology. 2009; 150:915-928.
15. Zygmunt M, Herr F, Keller-Schoenwetter S, et al. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab. 2002;87:5290-5296.
16. Berndt S, Perrier d'Hauterive S, Blacher S, et al. Angiogenic activity of human chorionic gonadot ropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J. 2006;20:2630-2632.
17. Balzan S, Del Carratore R, Nicolini G, et al. Proangiogenic effect of TSH i n human microvascular endothelial cells through its membrane receptor. J Clin Endocrinol Metab. 2012;97:1763-1770.
18. Donadeu FX, Ascoli M. The differential effects of the gonadotropin receptors on aro matase expression in primary cultures of immature rat granulosa cells are highly dependent on the density of receptors expressed and the activation of the inositol phosphate cascade. Endocrinology. 2005;146:3907-3916.
19. Thomas RM, Nechamen CA, Mazurkiewicz JE, Ulloa-Aguirre A, Dias JA. The adapter protein APPL1 links FSH receptor to inositol 1,4,5-trisphosphate production and is implicated in intracellular Ca(2-) mobilization. Endocrinology. 2011;152:1691-1701.
20. Lin YF, Tseng MJ, Hsu HL, Wu YW, Lee YH, Tsai YH. A novel follicle-stimulating hormone-induced G-h/phospholipase C-1 signaling pathway mediating rat Sert oli cell Ca2-influx. Mol Endocrinol. 2006;20:2514-2527.
21. Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell. 2006;125:247-260.
22. Nordhoff V, Sonntag B, von Tils D, et al. Effects of the FSH receptor gene polymorphism p.N680S on cAMP and steroid production in cultured primary human granulosa cells. Reprod Biomed Online. 2011;23:196-203.
23. Lang I, Pabst MA, Hiden U, et al. Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells. Eur J Cell Biol. 2003;82:163-173.
24. Siegel ET, Kim HG, Nishimoto HK, Layman LC. The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models. Reprod Sci. 2013;20:211-233.
25. AbelMH,WoottonAN,Wilkins V, Huhtaniemi I, Knight PG, Charlton HM. The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. Endocrinology. 2000;141:1795-1803.
26. Jaffe RB, Lee PA, MidgleyARJr. Serum gonadotropins before, at the inception of, and following human pregnancy. J Clin Endocrinol Metab. 1969;29:1281-1283.
27. Simoni M Khan SA Nieschlag E. Serum bioactive follicle-stimulating hormone-like activity in human pregnancy is a methodological artifact J Clin Endocrinol Metab. 1991 73 1118-1122
28. Palm M, Basu S, Larsson A, Wernroth L, A kerud H, Axelsson O. A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEG F-A) in normal pregnancy. Acta Obstet Gynecol Scand. 2011;90:1244-1251.
29. Huuskonen P, Storvik M, Reinisalo M, et al. Microarray analysis of the global alterations in the gene expression in the pla centas from cigarette-smoking mothers. Clin Pharmacol Ther. 2008;83:542-550.
30. Mikheev AM, Nabekura T, Kaddoumi A, et al. Profiling gene expression in human placentae of different gestational a ges: an OPRU Network and UW SCOR Study. Reprod Sci. 2008;15:866-877.
31. Votavova H, Dostalova Merkerova M, et al. Transcriptome alterations in maternal and fetal cells induced by tobacco smoke. Placenta. 2011;32:763-770.
32. Winn VD, Haimov-Kochman R, Paquet AC, et al. Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term. Endocrinology. 2007;148: 1059-1079.
33. Allen VM, Wilson RD, Cheung A. Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can. 2006;28: 220-250.
34. Sutcliffe AG, Ludwig M. Outcome of assisted reproduction. Lancet. 2007;370:351-359.
35. McDonald SD, Murphy K, Beyene J, Ohlsson A. Perinatel outcomes of singleton pr egnancies achieved by in vitro fertilization: a systematic review and meta-analysis. J Obstet Gynaecol Can. 2005;27: 449-459.
36. Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS . Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med. 2002;346:731-737.
37. Romundstad LB, Romundstad PR, Sunde A, et al. Effects o f technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study. Lancet. 2008;372:737-743.
38. Plunkett J, Doniger S, Orabona G, et al. An evolutionary genomic approach to identify genes involved in human birth timing. PLoS Genet 2011;7:e1001365.